3-Fluoro-2-methoxyisonicotinic acid
95%
- Product Code: 44665
CAS:
1214362-24-9
| Molecular Weight: | 171.1258432 g./mol | Molecular Formula: | C₇H₆FNO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD13185871 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a significant role in the creation of molecules with potential therapeutic properties, particularly in the development of drugs targeting neurological disorders and infectious diseases. Its structural features make it valuable for modifying drug candidates to enhance their efficacy, selectivity, and pharmacokinetic properties. Additionally, it is employed in organic synthesis for constructing complex heterocyclic compounds, which are often explored for their biological activities. Researchers also use it in the study of structure-activity relationships (SAR) to optimize drug design and improve therapeutic outcomes.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | €81.92 |
+
-
|
| 1.000 | 10-20 days | €228.42 |
+
-
|
3-Fluoro-2-methoxyisonicotinic acid
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a significant role in the creation of molecules with potential therapeutic properties, particularly in the development of drugs targeting neurological disorders and infectious diseases. Its structural features make it valuable for modifying drug candidates to enhance their efficacy, selectivity, and pharmacokinetic properties. Additionally, it is employed in organic synthesis for constructing complex heterocyclic compounds, which are often explored for their biological activities. Researchers also use it in the study of structure-activity relationships (SAR) to optimize drug design and improve therapeutic outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :